-
Product Insights
NewInterleukin 1 Beta – Drugs In Development, 2024
The Interleukin 1 Beta pipeline drugs market research report outlays comprehensive information on the Interleukin 1 Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Dermatology, Oncology, and Musculoskeletal Disorders which include indications of Inflammation, Rheumatoid Arthritis, Epidermolysis Bullosa, Hidradenitis Suppurativa, Squamous Non-Small Cell Lung Cancer, Metastatic Melanoma, Osteoarthritis, and Gouty Arthritis (Gout). It also reviews...
-
Product Insights
NewIntegrin Beta 3 – Drugs In Development, 2024
The Integrin Beta 3 pipeline drugs market research report outlays comprehensive information on the Integrin Beta 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Ophthalmology, Cardiovascular, and Dermatology which include indications of Breast Cancer, Glioblastoma Multiforme (GBM), Wet (Neovascular / Exudative) Macular Degeneration, Persistent Corneal Epithelial Defects, Thrombosis, Coronary Artery Disease (CAD) (Ischemic Heart Disease),...
-
Product Insights
NewCatenin Beta 1 – Drugs In Development, 2024
The Catenin Beta 1 pipeline drugs market research report outlays comprehensive information on the Catenin Beta 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Respiratory, Dermatology, and Non Malignant Disorders which include indications of Colorectal Cancer, Solid Tumor, Idiopathic Pulmonary Fibrosis, Scar, and Hemangiomas. It also reviews key players involved in Catenin Beta 1 targeted...
-
Product Insights
NewIntegrin Beta 5 – Drugs In Development, 2024
The Integrin Beta 5 pipeline drugs market research report outlays comprehensive information on the Integrin Beta 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Oncology, and Ophthalmology which include indications of Sepsis, Escherichia Coli Septicaemia, Breast Cancer, Glioblastoma Multiforme (GBM), Diabetic Macular Edema, and Keratoconjunctivitis Sicca (Dry Eye). It also reviews key players involved...
-
Product Insights
NewIntegrin Beta 2 – Drugs In Development, 2024
The Integrin Beta 2 pipeline drugs market research report outlays comprehensive information on the Integrin Beta 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, Infectious Disease, and Hematological Disorders which include indications of Immunology, Lupus Nephritis, Metastatic Melanoma, Solid Tumor, Unspecified Influenza Virus Infections, and Leukocyte Disorders (White Blood Cell Disorders). It also reviews...
-
Product Insights
NewBeta 3 Adrenergic Receptor – Drugs In Development, 2024
The Beta 3 Adrenergic Receptor pipeline drugs market research report outlays comprehensive information on the Beta 3 Adrenergic Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Genito Urinary System, Ophthalmology, Cardiovascular, and Gastrointestinal which include indications of Overactive Bladder, Neurogenic Bladder Dysfunction, Ocular Hypertension, Open-Angle Glaucoma, Congestive Heart Failure (Heart Failure), Left Ventricular Dysfunction, and Esophageal...
-
Product Insights
New11 Beta Hydroxysteroid Dehydrogenase – Drugs In Development, 2024
The 11 Beta Hydroxysteroid Dehydrogenase pipeline drugs market research report outlays comprehensive information on the 11 Beta Hydroxysteroid Dehydrogenase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Ophthalmology, Central Nervous System, and Immunology which include indications of Type 2 Diabetes, Diabetic Complications, Glaucoma, Diabetic Retinopathy, Alzheimer's Disease, Dementia Associated With Alzheimer's Disease, and Inflammation. It...
-
Product Insights
NewOxysterols Receptor LXR Beta – Drugs In Development, 2024
The Oxysterols Receptor LXR Beta pipeline drugs market research report outlays comprehensive information on the Oxysterols Receptor LXR Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Oncology, Central Nervous System, and Metabolic Disorders which include indications of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Dysfunction-Associated Steatohepatitis (MASH), Breast Cancer, Melanoma, Alzheimer's Disease, and Type 2...
-
Product Insights
NewBeta 1 Adrenergic Receptor – Drugs In Development, 2024
The Beta 1 Adrenergic Receptor pipeline drugs market research report outlays comprehensive information on the Beta 1 Adrenergic Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Ophthalmology, Immunology, and Central Nervous System which include indications of Congestive Heart Failure (Heart Failure), Idiopathic (Essential) Hypertension, Ocular Hypertension, Open-Angle Glaucoma, Anaphylaxis, Amyotrophic Lateral Sclerosis, and Chorea. It...
-
Product Insights
NewAmyloid Beta A4 Protein – Drugs In Development, 2024
The Amyloid Beta A4 Protein pipeline drugs market research report outlays comprehensive information on the Amyloid Beta A4 Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, Infectious Disease, and Ophthalmology which include indications of Alzheimer's Disease, Parkinson's Disease, Type 2 Diabetes, Amyloidosis, Coronavirus Disease 2019 (COVID-19), Infectious Disease, Glaucoma, and Age...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.